Cravath represented IBM in connection with the transaction. IBM announced it has acquired Polar Security, an innovator in technology that helps companies discover, continuously monitor and...
You must be a Standard 1 Year member to access this content.
Cravath is representing the Snyder family in connection with the transaction. The Washington Commanders and a partnership led by Josh Harris announced they have entered into...
You must be a Standard 1 Year member to access this content.
Cravath advised Kenvue, and Davis Polk advised the representatives of the underwriters involved in the IPO. Kenvue Inc. announced its $4.37 billion upsized initial public offering of...
You must be a Standard 1 Year member to access this content.
Cravath represented RELX in the transaction. LexisNexis® Risk Solutions, part of RELX, a global provider of information-based analytics and decision tools for professional and business customers, has...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore represented IBM in the transaction. IBM announced the acquisition of StepZen Inc, which developed a GraphQL server with a unique architecture that...
You must be a Standard 1 Year member to access this content.
Cravath and Dechert represented FS Investments in the transaction, while Simpson Thacher & Bartlett and Schulte Roth & Zabel represented Portfolio Advisors. FS Investments, a pioneer in...
You must be a Standard 1 Year member to access this content.
Cravath represented IBM in connection with the transaction while Morrison Foerster served as government contracts and regulatory counsel to Octo. IBM announced an agreement to acquire...
You must be a Standard 1 Year member to access this content.
Cravath represented Viatris in the transaction, while White & Case advised Famy Life Sciences. Famy Life Sciences, a market-leading drug development platform, announced its entry into...
You must be a Standard 1 Year member to access this content.
Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell advised Abiomed on the deal, while Cravath represented Johnson & Johnson. Davis Polk advised J.P. Morgan Securities LLC as financial adviser to Johnson...
You must be a Standard 1 Year member to access this content.
Allen & Overy and Cleary Gottlieb Steen & Hamilton LLP advised OpenText on the deal, while Cravath represented Micro Focus. Slaughter and May advised Micro Focus...
You must be a Standard 1 Year member to access this content.
White & Case advised Aramco, while Cravath, Swaine & Moore advised Valvoline on the deal. Aramco, one of the world’s largest integrated energy and chemical companies,...
You must be a Standard 1 Year member to access this content.
